knowledge -WSS

knowledge

author：focus 2025-09-07 00:17:33 - browse：59668

UnitedHealth Group appears to be offering some providers more substantial loans in the wake of the cyberattack on Change Healthcare, according to three doctors who each saw their advances increase up to seven figures.

The apparent change comes as hospitals, doctors, and lobbying groups have for weeks complained about low offers from the company, in some cases less than 1% of their typical weekly billing. Initially, after a mid-February cyberattack took its system offline, hampering insurers’ ability to receive claims and send payments, UnitedHealth offered loans to bridge the gap while the company worked to fix the outage, but many providers said it didn’t accomplish that.

It’s not clear exactly what prompted the change in these providers’ offers, or how broadly it applies. The new offers came just days after UnitedHealth officials met virtually with Health and Human Services Secretary Xavier Becerra and other White House officials. At that meeting, HHS said it explicitly asked UnitedHealth to send advance payments to providers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： European regulators recommend Amylyx's ALS drug be rejected

knowledge

WSS

How clinical AI models' predictive power can degrade over time

Takeaways from AdvaMed, the largest medical devices conference

How should state employee insurance handle Wegovy?

New report analyzes digital physical therapy solutions' effectiveness

How doctors and nurses shape Google's AI

European regulators consider appeal over Amylyx ALS drug

focus

knowledge

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT Virtual Event: ASCO Recap, Live!

Novavax promises a turnaround & Lilly roils the obesity market

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Trump demands the U.S. pay no more for drugs than other countries … again

European regulators recommend Amylyx's ALS drug be rejected

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Researchers CRISPR chickens in bid to protect them from bird flu

New air purifier tech could be key to improving indoor air quality

Statins may not be needed by millions of people, study suggests

focus

Female surgeons have lower rates of long

Lilly's Alzheimer's drug donanemab backed by FDA advisers

'Essentially witchcraft:' A former naturopath takes on the field

Medical device trials still don't enroll enough women, study finds

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Readout LOUD podcast: Merger Mondays, Ozempic panic

focus

knowledge

knowledge

focus